REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
University of Oxford
ClinicalTrials.gov Identifier:
NCT01252953
First received: November 24, 2010
Last updated: May 29, 2015
Last verified: May 2015